ClinicalTrials.gov
ClinicalTrials.gov Menu

Internet Cognitive Behavior Therapy (CBT) for Body Dysmorphic Disorder (BDD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01850433
Recruitment Status : Completed
First Posted : May 9, 2013
Last Update Posted : August 18, 2017
Sponsor:
Information provided by (Responsible Party):
Christian Rück, Karolinska Institutet

Brief Summary:
The primary aim is to develop, and test the feasibility, of a novel and protocol-based cognitive behaviour therapy (CBT) treatment for body dysmorphic disorder (BDD) administered via the Internet.

Condition or disease Intervention/treatment Phase
Body Dysmorhpic Disorder Behavioral: Internet based CBT for body dysmorphic disorder Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 23 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Internet-based Cognitive Behavior Therapy for Body Dysmorphic Disorder: A Pilot Study
Actual Study Start Date : March 2013
Actual Primary Completion Date : March 2014
Actual Study Completion Date : March 2014

Arm Intervention/treatment
Experimental: Internet CBT Behavioral: Internet based CBT for body dysmorphic disorder



Primary Outcome Measures :
  1. Body dysmorphic disorder symptoms [ Time Frame: Measured after 12 weeks of treatment, and after 3 months after treatment ]

Secondary Outcome Measures :
  1. Functioning and life satisfaction [ Time Frame: After 12 weeks of treatment, and 3 months after treatment ]
  2. Depressive symptoms [ Time Frame: After 12 weeks of treatment, and 3 months after treatment ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • outpatients
  • male or female

    -≥ 18 years

  • currently living in Stockholm county
  • primary diagnosis of BDD according to the DSM-IV-TR
  • signed informed consent
  • regular access to a computer with Internet access and skills to use the web.

Exclusion Criteria:

  • psychotropic medication changes within two months prior to the treatment
  • completed CBT for BDD within the last 12 months
  • BDD-YBOCS < 12 at psychiatrist visit
  • other primary axis I diagnosis
  • current substance dependence
  • lifetime bipolar disorder or psychosis
  • suicidal ideation
  • Axis II diagnosis that could jeopardize treatment participation
  • other current psychological treatment that could affect BDD symptoms

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01850433


Locations
Sweden
M46 Huddinge sjukhus, Internetpsykiatrienheten/mottagningen för tvångssyndrom
Stockholm, Sweden, 141 86
Sponsors and Collaborators
Karolinska Institutet
Investigators
Principal Investigator: Christian Rück, MD, PhD Karolinska Institutet

Additional Information:
Publications of Results:
Responsible Party: Christian Rück, Associate professor, M.D., Karolinska Institutet
ClinicalTrials.gov Identifier: NCT01850433     History of Changes
Other Study ID Numbers: BDD-P
First Posted: May 9, 2013    Key Record Dates
Last Update Posted: August 18, 2017
Last Verified: August 2017

Keywords provided by Christian Rück, Karolinska Institutet:
BDD
CBT

Additional relevant MeSH terms:
Disease
Body Dysmorphic Disorders
Pathologic Processes
Somatoform Disorders
Mental Disorders